Welcome. How can we help?
30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 2:00 p.m. Extremity Medical marked implantation of the 15,000th IO FiX device since global launch at the end of 2Q11. The fixation platform allows surgeons to generate high peak compression over a large surface area in joint fusion of the foot/ankle. (Source: Extremity Medical, LLC)
  • Implanet obtained CE Mark approval and FDA 510(k) clearance to market 3.5mm to 6mm JAZZ rods, adding to the original 5.5mm diameter clearance. (Source: Implanet)
  • OrthoSpace completed a financing transaction for an undisclosed amount. Proceeds will support market adoption, clinical study and entry into emerging markets for InSpace, a disruptive technology for the treatment of severe rotator cuff tears. (Source: OrthoSpace, Ltd.)
Read More

Articles of Interest All Articles

NuVasive Names Lucier as CEO

NuVasive appointed Gregory T. Lucier as CEO. Mr. Lucier had served as Interim CEO since April 1, when it was announced that Alex Lukianov resigned from his position. Mr. Lucier has served as a member of NuVasive’s Board of Directors since December 2013 and will continue his role as its Chairman.